expert specialist

Frank R. Berenson, M.D. (Medical Expert Witness)

(Medical Expert Background Info Summary)

Dr. Berenson is a Medical Expert Witness who is Board Certified in both Neurology and Pediatrics.  He is located in Atlanta, GA.  He states he has over 20 years of familiarity with phenobarbital and that he prescribes this drug to patients.  He has completed two separate Fellowships in Pediatric Neurology. He is currently a Clinical Assistant Professor of Pediatrics at a university.

Furthermore, he has experience in Teaching Conferences too. Some of these are – Pediatrics Case Management conference: Myoglobinuria and CPT deficiency (August 23, 1994), Neurology resident and medical student conference: Peripheral Neuropathy and Leights Disease (May 9, 1995), Core Curriculum lecture series: “Status Emil epticus, evaluation and management” (July 27, 1995) and A Day of Rehabilitation (Seminar) at Children’s Healthcare of Atlanta “Meningitis & Encephalitis: New Facts & Outcomes” (October 2000).

 

(Medical Expert Bullet Points of Interest)

  • M.D. from Medical College of Georgia (1985-1989)
  • Subspecialty Training: EMG 6 months – The Cleveland Clinic Foundation and University Hospitals of Cleveland
  • PANDA and Atlanta Headache Specialists, Atlanta, Georgia (January 2012 to Present)
  • Clinical Assistant Professor of Pediatrics at Mercer University, Macon, GA (2000 to Present)
  • American Academy of Neurology (1991 to Present)
  • American Academy of Pediatrics (1989 to Present)
  • American Headache Society (1992 to Present)
  • Principle Investigator for Drug Trails
  • Involved in Abstract Publications and Presentations
  • Experienced in Teaching Conferences

 

(Medical Expert Final Words/Short Summary)

Dr. Berenson has been the Principle Investigator for various Drug Trials. These include “An Open Label, Long Term Observational Study of Safety and Tolerability of Sumatriptan Nasal Spray in the Treatment of Migraine in Adolescents” – Protocol SUM 40276, Glaxo Wellcome, Inc. (2000-2001), “A Randomized, Open Label, Parallel-Groups, Outpatient Study to Examine the Long-Term Safety and Tolerability of Rizatriptan 5mg. P.O. for the Acute Treatment of Migraine in Adolescents” – Protocol MK-0462-061, MERCK Research Laboratories (2000-2001), “Randomized Double-Blind, Placebo-Controlled, Parallel Group, Single Attack Study to evaluate onset of Efficacy of a New Formulation of Sumatriptan Tablets (FDT) 50mg and 100mg in Acute Treatment of Migraine” – Protocol SUM 30047, GlaxoSmithKline (2003-2004) and “A Double-Blind, Multicenter, Randomized, Placebo-Controlled Study to evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches” – Protocol MT400-302, Pozen (2004-2005).

Dr. Berenson has also been a part of several abstract publications and presentations such as Focal Amyotrophy of Adolescence – American Academy of Electrophysiologic Medicine in Montreal, Canada (October 1995), Benign Myoclonus of Early Infancy: An Imitator of Infantile Spasms – Neurology 44 (Suppl. 2) p. A145 (April 1994) and Protean Clinical-EEG Manifestations of Temporal Lope Lesions in Infants – American Epilepsy Society (Dec. 1998).

(ExpertInfo.com – The Trusted Source for Expert Witness Services)

Are you looking for expert witness services? ExpertInfo.com is the trusted source for finding the right expert witness for your case. Our easy-to-use platform helps you quickly find the best expert witness near you. We have a vast network of highly credentialed experts from all over the world who specialize in various areas of expertise. With ExpertInfo.com, you can be confident that you’re getting the best expert witness services available.

Find Highly Credentialed Expert Witnesses Across All Disciplines, Industries, And Locations. Connecting Law Firms With Qualified Expert Witnesses Since 1987.

Share:

8937
Published: October 17, 2022
Views: 650
The Right Expert Right Away!

1-800-392-1119

Our Expert Database is Moving Online! Contact Us for More Options and Services.
© 2023 Expertinfo.com - All Rights Reserved.